Gye Ryeol Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gye Ryeol Park has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- A Hyeon Lee
Center for Nucleic Acid Therapies at the Department of Chemistry Institute for Chemical Epigenetics, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, 81377 München, Germany
1 shared publication - Dae Won Jun
Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Korea
1 shared publication - Eileen Laurel Yoon
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
1 shared publication - Hye Young Kim
Department of Translational Medicine, Graduate School of Biomedical Science and Engineering Hanyang University Seoul South Korea
1 shared publication - Ju Hee Oh
Department of Obstetrics and Gynecology, Institute of Women’s Medical Life Science, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
1 shared publication - Seung Min Lee
Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Republic of Korea
1 shared publication
Latest Publications
- 9 October 2023
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 38 (12) , 2206-2214
Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis
Background and Aim: Necroptosis is an emerging cell death pathway that allows cells to undergo “cellular suicide” in a caspase‐independent manner. We investigated the fate of hepatic stellate cells (HSCs) under necroptotic stimuli.Methods and Results: The RNA level of mixed lineage kinase domain‐like protein (MLKL) is higher in patients with non‐alcoholic fatty liver disease than in healthy controls. Hepatic fibrosis was significantly lower in MLKL‐KO bile duct ligation (KO‐BDL) mice than in wild‐type‐BDL mice. Necroptotic stimuli caused the death of HT‐29 and U937 cells. However, necroptotic stimuli activate HSCs instead of inducing cell death. MLKL inhibitors attenuated fibrogenic changes in HSCs during necroptosis. Unlike HT‐29 and U937 cells, MLKL phosphorylation and oligomerization were not observed during necroptosis in HSCs. RNA sequencing showed that NF‐κB signaling‐related genes were upregulated in HSCs following necroptotic stimulation. Necroptotic stimuli in HSCs increased the nuclear expression of NF‐κB, which decreased after MLKL inhibitor treatment. Induction of necroptosis in HSCs led to autophagosome activation and formation, which were attenuated by MLKL inhibitor treatment.Conclusion: HSCs avoid necroptosis due to the absence of MLKL phosphorylation and oligomerization and are activated through autophagosome and NF‐κB pathways.
- 9 October 2023
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 38 (12) , 2206-2214
Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis
Background and Aim: Necroptosis is an emerging cell death pathway that allows cells to undergo “cellular suicide” in a caspase‐independent manner. We investigated the fate of hepatic stellate cells (HSCs) under necroptotic stimuli.Methods and Results: The RNA level of mixed lineage kinase domain‐like protein (MLKL) is higher in patients with non‐alcoholic fatty liver disease than in healthy controls. Hepatic fibrosis was significantly lower in MLKL‐KO bile duct ligation (KO‐BDL) mice than in wild‐type‐BDL mice. Necroptotic stimuli caused the death of HT‐29 and U937 cells. However, necroptotic stimuli activate HSCs instead of inducing cell death. MLKL inhibitors attenuated fibrogenic changes in HSCs during necroptosis. Unlike HT‐29 and U937 cells, MLKL phosphorylation and oligomerization were not observed during necroptosis in HSCs. RNA sequencing showed that NF‐κB signaling‐related genes were upregulated in HSCs following necroptotic stimulation. Necroptotic stimuli in HSCs increased the nuclear expression of NF‐κB, which decreased after MLKL inhibitor treatment. Induction of necroptosis in HSCs led to autophagosome activation and formation, which were attenuated by MLKL inhibitor treatment.Conclusion: HSCs avoid necroptosis due to the absence of MLKL phosphorylation and oligomerization and are activated through autophagosome and NF‐κB pathways.